SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-159251
Filing Date
2020-06-03
Accepted
2020-06-03 11:27:03
Documents
7
Period of Report
2020-06-03

Document Format Files

Seq Description Document Type Size
1 6-K d938441d6k.htm 6-K 16638
2 EX-99.1 d938441dex991.htm EX-99.1 14513
3 EX-99.2 d938441dex992.htm EX-99.2 12220
4 EX-99.3 d938441dex993.htm EX-99.3 53834
5 EX-99.4 d938441dex994.htm EX-99.4 11405
6 EX-99.5 d938441dex995.htm EX-99.5 6802
7 GRAPHIC g938441g0602174614435.jpg GRAPHIC 2535
  Complete submission text file 0001193125-20-159251.txt   120193
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 20939319
SIC: 2834 Pharmaceutical Preparations